Greater self-reported physical disability within the first years of being diagnosed with relapsing-remitting multiple sclerosis (MS) is associated with…
Articles by Lindsey Shapiro, PhD
An anti-inflammatory diet combined with synbiotic supplements eased fatigue, pain, sexual dysfunction, and bladder and bowel problems in people with…
An energy management education program combined with high-intensity exercise during a three-week inpatient rehabilitation program didn’t lead to quality of…
A course of neuromuscular electrical stimulation using Neufit‘s neuro-bio-electric stimulator — a device dubbed Neubie — alongside physical therapy…
The U.S. Food and Drug Administration (FDA) has approved Tyruko (natalizumab-sztn) as the first biosimilar of Tysabri to…
ASH41020, an investigational therapy from Ashvattha Therapeutics, significantly reduced disease severity and exhibited immunomodulatory properties in a mouse model…
Noninvasive brain stimulation (NIBS) may offer promise for treating spasticity in multiple sclerosis (MS), but more work is…
Older age and greater physical disability when starting a disease-modifying therapy (DMT) were linked to worse cognitive function for…
Delivering an antibody against the Nogo-A protein to a specific region of the nose called the olfactory mucosa improved motor…
A lab-engineered probiotic, composed of live bacteria that colonize the gut, was able to ease signs of disease in a…
Researchers have developed a vaccine against the Epstein-Barr virus (EBV) — a leading environmental risk factor for multiple…
More daily physical activity, better physical condition, and lower disability were all associated with less fatigue for people with…
Treatment with ibudilast — an anti-inflammatory being developed to treat people with progressive forms of multiple sclerosis (MS) —…
The U.S. Food and Drug Administration (FDA) has agreed to review Viatris and Mapi Pharma‘s application seeking approval…
For the first time, multiple sclerosis (MS) therapies have been added to the World Health Organization (WHO)’s Model…
Dawn Health, a Danish digital health company, has developed a smartphone app to support and empower people living with…
The risk of developing multiple sclerosis (MS) was similar between first- and second-degree family members of people with…
What a person eats in childhood can influence their future risk of developing multiple sclerosis (MS) and its clinical…
The presence of spinal cord lesions — alone or with brain lesions — on MRI scans was associated with a…
INmune Bio‘s experimental therapy XPro1595 may promote myelin restoration through the activation of two types of nervous system support…
Tysabri (natalizumab) is better than five other disease-modifying therapies (DMTs) at reducing relapses and preventing disability worsening in…
Adding optic nerve damage — reflected by a thinning of the nerve layer in the eye’s retina — to the…
Women with multiple sclerosis (MS) are three times more likely to face problems with sexual intimacy than are their…
Nerve cells coated with myelin — the fatty substance that’s lost in multiple sclerosis (MS) — may be…
Researchers have developed computer algorithms that may be able to predict certain aspects of cognitive change in multiple sclerosis…
Diet was found to significantly influence the severity of multiple sclerosis (MS) symptoms among patients living in Denmark in…
People with multiple sclerosis (MS) should generally follow a regular vaccination schedule similar to their healthy peers, with certain…
Ocrevus (ocrelizumab) — given by infusion — may work better than certain oral treatments to prevent relapses and disability…
Reductions in microglial activation have been observed in the brains of five of six patients with nonactive secondary progressive…
Physical disability, not whether patients are depressed, when they’re diagnosed with multiple sclerosis significantly influences their future disability progression,…